American Association for Cancer Research, Clinical Cancer Research, 10(28), p. 1996-1998, 2022
DOI: 10.1158/1078-0432.ccr-22-0214
Full text: Download
SummaryAn unbiased approach to map the sentinel lymph node landscape reveals progressive immune dysfunction associated with micrometastasis in patients with stage I–III cutaneous melanoma. Evidence of tumor-induced lymph node dysfunction may motivate new hypotheses for neoadjuvant therapy with potential to reinvigorate endogenous antitumor immunity.See related article by Yaddanapudi et al., p. 2069